相关实验视频
Updated: Jan 31, 2026

05:39
Isolation of Tissue Extracellular Vesicles from the Liver
Published on: August 21, 2019
12.4K
细菌细胞外囊泡在肝脏疾病的发病和治疗中的作用
Yakun Li1, Jia Li1, Robin P F Dullaart2
1Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Journal of gastroenterology and hepatology
|January 30, 2026
概括
细菌细胞外囊泡 (BEVs) 显著影响肝病,其中一些促进病理,而另一些则提供保护. 了解BEV是开发新肝病治疗方法的关键.
科学领域:
- 微生物学 微生物学
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝脏疾病对全球健康造成重大负担,治疗选择有限.
- 肠道微生物群及其代谢物越来越多地被认为在肝脏疾病中的作用.
- 细菌细胞外囊泡 (BEVs) 正在成为肝脏病理中的关键调解者.
研究的目的:
- 为提供细菌细胞外囊泡 (BEVs) 在肝病中的综合性审查.
- 阐明BEVs在促进和保护肝脏病理方面的双重作用.
- 讨论治疗应用的BEV研究中的挑战和未来方向.
主要方法:
- 对细菌细胞外囊泡和肝脏疾病研究的文献综述.
- 对BEVs影响肝炎,纤维化和新陈代谢的机制的分析.
- 综合关于BEVs治疗潜力的当前知识.
主要成果:
- 致病性BEVs有助于肝炎,纤维化,代谢失调和瘤发生.
- 交叉体和益生菌衍生的BEV显示出对肝脏疾病的保护作用.
- BEVs代表了一种新的分子类别,对肝脏健康有重大影响.
结论:
- 在肝脏疾病的发病和潜在治疗中,BEVs是关键参与者.
- 针对或利用BEV为肝脏疾病提供了有前途的治疗途径.
- 需要进一步的研究来克服挑战,并充分利用BEVs在肝病管理中的潜力.
相关概念视频
Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
946
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
946
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
485
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
485
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
199
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
199
Pulmonary Hypertension: Classification and Pathogenesis
642
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
642

